Clinical Trial to Evaluate the Pharmacokinetic Characteristics of DW5221 and DW5221-R

A Bioequivalence Study to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety After Administration of DW5221 and DW5221-R in Healthy Adult Male Volunteers

A bioequivalence study to compare and evaluate the pharmacokinetic characteristics and the safety after administration of DW5221 and DW5221-R in healthy adult m ale volunteers

Inclusion Criteria:

• Healthy Male Volunteers who are ≥19 years old
• Body weight ≥50.0 kg and BMI between 18.0 and 30.0 kg/m2 and

Exclusion Criteria:

• Clinically significant Medical History